51
Participants
Start Date
December 31, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2029
A.1 - [¹⁸F]F-AraG PET/CT (90-min dynamic + 4-h static)
Participants receive an intravenous injection of 5 mCi (±20%) of \[¹⁸F\]F-AraG followed by a 90-minute total-body PET/CT scan and an additional 30-minute static scan at 4 hours post-injection. Blood samples (up to 42 mL total) are collected during dynamic imaging.
A.2 - [¹⁸F]F-AraG PET/CT (60-min dynamic only)
Participants receive an intravenous injection of 5 mCi (±20%) of \[¹⁸F\]F-AraG followed by a 60-minute total-body PET/CT scan. Blood samples (up to 42 mL total) are collected during dynamic imaging.
B.1 - [¹⁸F]F-AraG PET/CT (90-min dynamic + 4-h static)
Participants receive an intravenous injection of 5 mCi (±20%) of \[¹⁸F\]F-AraG followed by a 90-minute total-body PET/CT scan and a second 30-minute scan at 4 hours. Blood samples (up to 42 mL total) are collected during dynamic imaging.
B.2 - [¹⁸F]F-AraG PET/CT (60-min dynamic only)
Participants receive 5 mCi (±20%) of \[¹⁸F\]F-AraG intravenously followed by a 60-minute total-body PET/CT scan. Blood samples (up to 42 mL total) are collected during dynamic imaging.
University of California San Francisco, San Francisco
UC Davis EXPLORER Molecular Imaging Center, Sacramento
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of California, San Francisco
OTHER
University of California, Davis
OTHER